rs191549504

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_006772.3(SYNGAP1):ā€‹c.3344T>Cā€‹(p.Ile1115Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0136 in 1,512,836 control chromosomes in the GnomAD database, including 183 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0091 ( 11 hom., cov: 31)
Exomes š‘“: 0.014 ( 172 hom. )

Consequence

SYNGAP1
NM_006772.3 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.654
Variant links:
Genes affected
SYNGAP1 (HGNC:11497): (synaptic Ras GTPase activating protein 1) This gene encodes a Ras GTPase activating protein that is a member of the N-methyl-D-aspartate receptor complex. The N-terminal domain of the protein contains a Ras-GAP domain, a pleckstrin homology domain, and a C2 domain that may be involved in binding of calcium and phospholipids. The C-terminal domain consists of a ten histidine repeat region, serine and tyrosine phosphorylation sites, and a T/SXV motif required for postsynaptic scaffold protein interaction. The encoded protein negatively regulates Ras, Rap and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking to the postsynaptic membrane to regulate synaptic plasticity and neuronal homeostasis. Allelic variants of this gene are associated with intellectual disability and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
SYNGAP1-AS1 (HGNC:53831): (SYNGAP1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SYNGAP1. . Gene score misZ 5.6047 (greater than the threshold 3.09). Trascript score misZ 7.6762 (greater than threshold 3.09). GenCC has associacion of gene with autosomal dominant non-syndromic intellectual disability, complex neurodevelopmental disorder, intellectual disability, autosomal dominant 5, SYNGAP1-related developmental and epileptic encephalopathy, myoclonic-astatic epilepsy.
BP4
Computational evidence support a benign effect (MetaRNN=0.005625069).
BP6
Variant 6-33443896-T-C is Benign according to our data. Variant chr6-33443896-T-C is described in ClinVar as [Benign]. Clinvar id is 130530.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-33443896-T-C is described in Lovd as [Benign]. Variant chr6-33443896-T-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00909 (1366/150224) while in subpopulation NFE AF= 0.0131 (882/67402). AF 95% confidence interval is 0.0124. There are 11 homozygotes in gnomad4. There are 697 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1366 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYNGAP1NM_006772.3 linkuse as main transcriptc.3344T>C p.Ile1115Thr missense_variant 15/19 ENST00000646630.1
SYNGAP1-AS1NR_174954.1 linkuse as main transcriptn.329+2710A>G intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYNGAP1ENST00000646630.1 linkuse as main transcriptc.3344T>C p.Ile1115Thr missense_variant 15/19 NM_006772.3 P1Q96PV0-1
SYNGAP1-AS1ENST00000630418.1 linkuse as main transcriptn.377+2710A>G intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00910
AC:
1366
AN:
150108
Hom.:
11
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00297
Gnomad ASJ
AF:
0.00347
Gnomad EAS
AF:
0.00745
Gnomad SAS
AF:
0.00383
Gnomad FIN
AF:
0.0251
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0131
Gnomad OTH
AF:
0.00632
GnomAD3 exomes
AF:
0.00979
AC:
1614
AN:
164858
Hom.:
16
AF XY:
0.0101
AC XY:
900
AN XY:
88864
show subpopulations
Gnomad AFR exome
AF:
0.00212
Gnomad AMR exome
AF:
0.00288
Gnomad ASJ exome
AF:
0.00557
Gnomad EAS exome
AF:
0.00675
Gnomad SAS exome
AF:
0.00226
Gnomad FIN exome
AF:
0.0229
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.00912
GnomAD4 exome
AF:
0.0141
AC:
19170
AN:
1362612
Hom.:
172
Cov.:
62
AF XY:
0.0137
AC XY:
9140
AN XY:
666582
show subpopulations
Gnomad4 AFR exome
AF:
0.00155
Gnomad4 AMR exome
AF:
0.00264
Gnomad4 ASJ exome
AF:
0.00466
Gnomad4 EAS exome
AF:
0.0254
Gnomad4 SAS exome
AF:
0.00188
Gnomad4 FIN exome
AF:
0.0204
Gnomad4 NFE exome
AF:
0.0153
Gnomad4 OTH exome
AF:
0.00915
GnomAD4 genome
AF:
0.00909
AC:
1366
AN:
150224
Hom.:
11
Cov.:
31
AF XY:
0.00950
AC XY:
697
AN XY:
73364
show subpopulations
Gnomad4 AFR
AF:
0.00242
Gnomad4 AMR
AF:
0.00297
Gnomad4 ASJ
AF:
0.00347
Gnomad4 EAS
AF:
0.00747
Gnomad4 SAS
AF:
0.00383
Gnomad4 FIN
AF:
0.0251
Gnomad4 NFE
AF:
0.0131
Gnomad4 OTH
AF:
0.00625
Alfa
AF:
0.0113
Hom.:
14
Bravo
AF:
0.00699
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.00934
AC:
36
ESP6500AA
AF:
0.00255
AC:
11
ESP6500EA
AF:
0.0103
AC:
87
ExAC
AF:
0.00887
AC:
1014
Asia WGS
AF:
0.00549
AC:
19
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsSep 15, 2016- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 25, 2019- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024SYNGAP1: PP2, BS1, BS2 -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 06, 2020- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJun 11, 2015- -
Intellectual disability, autosomal dominant 5 Benign:2
Benign, criteria provided, single submittercurationSIB Swiss Institute of BioinformaticsMay 31, 2018This variant is interpreted as a Benign, for Mental retardation, autosomal dominant 5, in Autosomal Dominant manner. The following ACMG Tag(s) were applied: BP4 => Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.). BS1 =>Allele frequency is greater than expected for disorder. BS2 => Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age (PMID:19196676, 21237447). -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 19, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
SYNGAP1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 05, 2021This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
20
DANN
Benign
0.76
DEOGEN2
Benign
0.026
T;T;.;.;.;.;.;.
Eigen
Benign
-0.57
Eigen_PC
Benign
-0.38
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.88
.;D;D;D;D;D;D;D
MetaRNN
Benign
0.0056
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.0
N;N;.;.;N;N;.;.
MutationTaster
Benign
0.99
N;N;N;N
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.020
.;.;.;N;.;N;N;.
REVEL
Benign
0.10
Sift
Benign
0.58
.;.;.;T;.;T;T;.
Sift4G
Benign
0.41
.;T;.;T;T;T;T;.
Polyphen
0.0
B;B;.;.;B;B;.;.
Vest4
0.19, 0.21, 0.22, 0.19
MVP
0.082
MPC
1.4
ClinPred
0.0011
T
GERP RS
1.9
Varity_R
0.064
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs191549504; hg19: chr6-33411673; API